These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2556168)

  • 1. The release of chromogranin A and B like activity from human lung cancer cell lines. A potential marker for a subset of small cell lung cancer.
    Bergh J; Arnberg H; Eriksson B; Lundqvist G
    Acta Oncol; 1989; 28(5):651-4. PubMed ID: 2556168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of chromogranin A and B derived peptides in human small cell lung carcinoma cell lines.
    Iguchi H; Bannai S; Takanashi N; Tsukada Y
    Eur J Cancer; 1992; 28A(8-9):1458-62. PubMed ID: 1325178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
    Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
    Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay.
    Deftos LJ; Linnoila RI; Carney DN; Burton DW; Leong SS; O'Connor DT; Murray SS; Gazdar AF
    Cancer; 1988 Jul; 62(1):92-7. PubMed ID: 2838150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranins--new sensitive markers for neuroendocrine tumors.
    Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
    Acta Oncol; 1989; 28(3):325-9. PubMed ID: 2545231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
    Poola I; Graziano SL
    J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
    Kobayashi S; Okada S; Hasumi T; Sato N; Fujimura S
    Tohoku J Exp Med; 1999 Sep; 189(1):37-49. PubMed ID: 10622207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
    Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
    Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties.
    Marini AM; Fridman R; Kanemoto T; Martin GR; Guo Y; Passaniti A
    J Natl Cancer Inst; 1992 Oct; 84(20):1582-7. PubMed ID: 1328660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative proteomics of small cell lung carcinoma.
    Ziv T; Barnea E; Segal H; Sharon R; Beer I; Admon A
    Cancer Biomark; 2006; 2(6):219-34. PubMed ID: 17264394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator modulates neurosecretory function in pulmonary neuroendocrine cell-related tumor cell line models.
    Pan J; Bear C; Farragher S; Cutz E; Yeger H
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):553-60. PubMed ID: 12397014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
    Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
    Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung.
    Portela-Gomes GM; Grimelius L; Stridsberg M; Bresaola E; Viale G; Pelosi G
    Virchows Arch; 2005 Jun; 446(6):604-12. PubMed ID: 15906087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype.
    King PH
    Int J Cancer; 1997 Aug; 74(4):378-82. PubMed ID: 9291425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
    Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
    J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
    Bepler G; Jaques G; Koehler A; Gropp C; Havemann K
    J Cancer Res Clin Oncol; 1987; 113(3):253-9. PubMed ID: 2438285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
    Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
    Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinoma.
    Mulligan LM; Timmer T; Ivanchuk SM; Campling BG; Young LC; Rabbitts PH; Sundaresan V; Hofstra RM; Eng C
    Genes Chromosomes Cancer; 1998 Apr; 21(4):326-32. PubMed ID: 9559344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin.
    Poulsen TT; Pedersen N; Perin MS; Hansen CK; Poulsen HS
    Lung Cancer; 2005 Dec; 50(3):329-37. PubMed ID: 16115696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy.
    Brenner S; Klameth L; Riha J; Schölm M; Hamilton G; Bajna E; Ausch C; Reiner A; Jäger W; Thalhammer T; Buxhofer-Ausch V
    Cancer Lett; 2015 Jan; 356(2 Pt B):517-24. PubMed ID: 25301452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.